Defence Finance Monitor #237
Defence Finance Monitor applies a top–down method that traces how NATO, EU and allied strategic priorities are translated into regulations, funding lines and procurement programmes, and then into demand for specific capabilities, technologies and companies. We use official doctrine as the organising frame to identify where strategic relevance is being institutionally defined and where it is materialising in concrete budgets, acquisition pathways and industrial capacity.
Our working assumption is that what becomes structurally relevant in NATO/EU strategy tends, over time, to become relevant also from a financial and industrial point of view. In the European context, this includes the progressive operationalisation of strategic autonomy: the effort to reduce critical dependencies, secure supply chains, strengthen the European defence technological and industrial base, and align regulatory, financial and procurement instruments with long-term security objectives. On this basis, DFM operates as a decision-support tool: it benchmarks investment and industrial choices against institutional demand, clarifies which capabilities are rising on the spending agenda, and maps the funding instruments, eligibility constraints and supply-chain factors that shape real-world feasibility across investors, industry, public authorities and research organisations.
Defence Finance Monitor rests on a single analytical premise: within the Euro-Atlantic security architecture, strategic doctrine precedes regulation and capability planning, regulation precedes budgets, and budgets shape markets.
Strategy · Great-Power Competition
Rich, Disarmed, Divided
In a world reorganising itself into blocs, the question a continent must ask is not what seat it will take at the table, but whether it will sit at the table at all — or be what those at the table divide among themselves. This report argues that Europe now risks precisely that condition: a continent rich enough to be worth contesting, yet stripped of the means to remove itself from the contest. Two revisionist powers are moving in, by different roads — Russia through military coercion and subversion, China through economic penetration — and the analysis shows why the two campaigns reinforce rather than run parallel to one another, since a militarily dependent Europe lacks the freedom to defend even its own commercial interests. The three certainties on which European prosperity rested — cheap Russian energy, boundless Chinese markets, American security — have fallen away together. The piece traces how that weakness arose, why tariffs and screening alone arrive late and disunited, why active competitiveness is the only durable defence, and what it would take to be a subject of the history to come rather than its object.
The full analysis is reserved for DFM paid subscribers.
Health Security · Industrial Resilience
Health Security, Critical Medicines and Biomanufacturing
Europe’s health-security problem is no longer a matter of hospital budgets or reimbursement. It is an industrial-capacity question, and it sits inside the everyday medicine base rather than a small set of exotic emergency products. For generic medicines, an estimated 60 to 80 per cent of active-ingredient production has been outsourced to China; the Union list of critical medicines now covers roughly three-quarters of authorised products; and the European Court of Auditors found record shortages in 2023 and 2024 with no effective framework yet in place. This report treats health security as a map of strategic functions rather than a life-sciences market. It works through the legal architecture — the still-pending Critical Medicines Act, HERA, EMA’s shortage platform, the European Health Data Space — and maps four classes of asset that materially reduce dependency: direct substitution in APIs and sterile production, reservable surge capacity, enabling technologies such as bioprocess equipment and drug containment, and the visibility infrastructures that let Europe see scarcity before it arrives rather than after.
The complete asset map — across all four classes — is available to DFM subscribers.
Chemicals · Strategic Molecules
Chemicals, Fertilisers and Strategic Molecules
Chemicals are the industry the others are built on: the European Commission calls the sector the “industry of the industries” and notes it contributes to more than 96 per cent of manufactured goods. That is why its erosion is now an economic-security problem, not a competitiveness footnote. The EU’s global market share has more than halved since 2003, over twenty major upstream sites — crackers, ammonia and other plants — were announced for closure in two years, and when a single node exits, the loss propagates through polymers, battery materials, pharmaceutical intermediates, semiconductor chemicals and defence-relevant inputs. Ammonia shows the mechanism most starkly: gas is over 70 per cent of its variable cost, so Europe’s exposure appears not only when imports are blocked but when domestic output becomes uneconomic. This report maps the molecule-and-process chains behind agriculture, defence, pharma, batteries and chips, shows how regulation now functions as a selection mechanism deciding which molecules Europe keeps, and sets out the signals to monitor as Brussels begins to govern chemistry as infrastructure.
The full molecule-and-company map is reserved for DFM paid subscribers.
Industrial Base · Production Sovereignty
Advanced Manufacturing, Robotics and Machine Tools
Excellent factories are not the same thing as control over scale-up — and that distinction is where Europe’s strategic autonomy is quietly decided. Strategy documents, defence budgets and platform designs become real capacity only when production systems can be scaled, reconfigured, qualified and kept within tolerance under stress, through machine tools, robotics, factory software, metrology and certification. Europe retains genuine depth here, but the vulnerabilities are precise: only one euro in ten invested globally in advanced manufacturing reaches European firms, and some of the continent’s best-known robotics names are European in footprint yet foreign in ultimate ownership. This report separates presence from control, maps the company categories that actually matter — machine-tool builders, automation groups, metrology and certification firms, the enabling suppliers behind them — and sets out eight variables to watch through 2030, from robot diffusion beyond the leaders to ownership of the software, data and certification layers on which modern production now depends.
The complete company map — presence versus control — is available to DFM subscribers.
DFM Professional Packs
Defence Finance Monitor is pleased to introduce the DFM Professional Packs, a new line of downloadable tools that help organisations prepare for the regulatory reality of Europe’s defence market. As EU funding and contracts increasingly flow through overlapping tests of ownership and control, component origin, dual-use classification, foreign-investment screening and security of supply — across EDIP, SAFE, EDF and the incoming FDI framework — companies, investors and their advisers are expected to have this groundwork in order well before they reach a prime contractor, an authority or an investment committee. The Packs give them a disciplined way to do exactly that: to gather the facts, ask the right questions and surface preliminary flags in-house, before specialist advisers are engaged.
The line comprises three self-contained products. The EU Defence Eligibility & Control Pack structures a full internal screen across eligibility, ownership and control, dual-use exposure and FDI; the Defence M&A Regulatory Screening Pack is tuned to the regulatory work-stream of a transaction, from FDI risk mapping to export-control due diligence; and the EDIP/SAFE/EDF Procurement Readiness Pack prepares SMEs and suppliers for programme participation and prime onboarding. Each Pack pairs an article-cited screening workbook with editable Word templates and a Source Register that links every instrument to its CELEX number and official EUR-Lex text. They are preliminary-preparation tools — not legal, export-control or investment advice, and they never determine eligibility; that discipline is precisely the point. Available now as a one-off purchase, with immediate download and no subscription, from €590.